Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

GIMEMA, European Research Initiative (ERIC) on CLL, US study group

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study'. Together they form a unique fingerprint.

Medicine & Life Sciences